Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

Autor: Gadgeel, Shirish M, Gandhi, Leena, Riely, Gregory J, Chiappori, Alberto A, West, Howard L, Azada, Michele C, Morcos, Peter N, Lee, Ruey-Min, Garcia, Linta, Yu, Li, Boisserie, Frederic, Di Laurenzio, Laura, Golding, Sophie, Sato, Jotaro, Yokoyama, Shumpei, Tanaka, Tomohiro, Ou, Sai-Hong Ignatius

Publikováno v: In Lancet Oncology September 2014 15(10):1119-1128

P1142: AFM13 IN PATIENTS WITH R/R PERIPHERAL T CELL LYMPHOMA (PTCL): A POST‐HOC SUBGROUP ANALYSIS FROM THE REDIRECT STUDY.

Autor: Kim, Won‐Seog, Shortt, Jake, Luigi Zinzani, Pier, Mikhaylova, Natalya, Marin‐Niebla, Ana, Radeski, Dejan, Ribrag, Vincent, Domingo Domènech, Eva, Sawas, Ahmed, Alexis, Karenza, Emig, Michael, Garcia, Linta, Overesch, Andre, Pietzko, Kerstin, Horwitz, Steven

Publikováno v: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase 2 study of acimtamig (AFM13) in patients with CD30-positive, relapsed or refractory peripheral T-cell lymphomas.

Autor: Kim WS; Samsung Medical Center, Seoul, Korea (South), Republic of., Shortt J; Monash University, Clayton, Victoria, Australia., Zinzani PL; University of Bologna, Bologna, Italy., Mikhailova N; Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia., Radeski D; Columbia University Medical Center, NY, NY, United States., Ribrag V; Institut Gustave Roussy, Villejuif, France., Domingo Domenech E; Duran i Reynals Hospital, Spain., Sawas A; Columbia University Medical Center, New York, NY, United States., Alexis K; Affimed Inc, United States., Emig M; Affimed GmbH, Mannheim, Germany., Elbadri R; Affimed GmbH, Germany., Hajela P; Affimed GmbH, Germany., Ravenstijn P; Affimed GmbH, Mannheim, Germany., Pinto S; Affimed GmbH, Germany., Garcia L; Affimed Inc, Jersey City, United States., Overesch A; Affimed GmbH, Mannheim, Baden-Württemberg, Germany., Pietzko K; Affimed GmbH, Mannheim, Germany., Horwitz S; Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.